Skip to main content

Table 1 Baseline characteristics at enrolment, by treatment group

From: Efficacy of two artemisinin-based combinations for the treatment of malaria in pregnancy in India: a randomized controlled trial

  AS+SP (N = 125) AS+MQ (N = 123) Total (N = 248) P-value
Age (years)a 23.1 ± 3.9 23.6 ± 3.7 23.4 ± 3.8 0.2758
Gestation (weeks)a 25.5 ± 6.2 24.8 ± 5.7 25.14 ± 5.95 0.3660
Hb (g/dL)a 8.8 ± 1.1 9.1 ± 1.3 8.96 ± 1.2 0.1126
Asexual parasitaemia/µLa [median (range)] 16,261 ± 30,494 [2800 (32–165,520)] 17,126 ± 30,705 [2220 (32–153,000)] 16,695 ± 30,540 [2400 (32–165,520)] 0.8257
Gametocyte carriage 5 (4.0) 5 (4.1) 10 (4.0)  
Gravidity
 1 57 (45.6) 52 (42.3) 109 (44.0) 0.5998
 2 37 (29.6) 38 (30.9) 75 (30.2) 0.8253
 3+ 31 (24.8) 33 (26.8) 64 (25.8) 0.7163
Parity
 0 64 (51.2) 61 (49.6) 125 (50.4) 0.8012
 1 36 (28.8) 40 (32.5) 76 (30.6) 0.5271
 2+ 25 (20.0) 22 (17.9) 47 (19.0) 0.6726
  1. aMean ± SD; percentages in brackets